ATE244298T1 - Methode zur identifizierung von immungeschwächter patienten mit einem hohen risiko für cryptococcosis durch dem igg antikörperstand gegen glucoronoxylomannan zu titrieren - Google Patents

Methode zur identifizierung von immungeschwächter patienten mit einem hohen risiko für cryptococcosis durch dem igg antikörperstand gegen glucoronoxylomannan zu titrieren

Info

Publication number
ATE244298T1
ATE244298T1 AT95918344T AT95918344T ATE244298T1 AT E244298 T1 ATE244298 T1 AT E244298T1 AT 95918344 T AT95918344 T AT 95918344T AT 95918344 T AT95918344 T AT 95918344T AT E244298 T1 ATE244298 T1 AT E244298T1
Authority
AT
Austria
Prior art keywords
cryptococcosis
high risk
glucoronoxylomannan
titrating
igg antibody
Prior art date
Application number
AT95918344T
Other languages
English (en)
Inventor
Thomas R Kozel
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of ATE244298T1 publication Critical patent/ATE244298T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G01N33/547—Synthetic resin with antigen or antibody attached to the carrier via a bridging agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT95918344T 1994-05-02 1995-04-27 Methode zur identifizierung von immungeschwächter patienten mit einem hohen risiko für cryptococcosis durch dem igg antikörperstand gegen glucoronoxylomannan zu titrieren ATE244298T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/236,331 US5677137A (en) 1994-05-02 1994-05-02 Method to identify immunocompromised patients at high risk for cryptococcosis
PCT/US1995/005391 WO1995029985A1 (en) 1994-05-02 1995-04-27 Method to identify immunocompromised patients at high risk for cryptococcosis

Publications (1)

Publication Number Publication Date
ATE244298T1 true ATE244298T1 (de) 2003-07-15

Family

ID=22889066

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95918344T ATE244298T1 (de) 1994-05-02 1995-04-27 Methode zur identifizierung von immungeschwächter patienten mit einem hohen risiko für cryptococcosis durch dem igg antikörperstand gegen glucoronoxylomannan zu titrieren

Country Status (15)

Country Link
US (1) US5677137A (de)
EP (1) EP0758375B1 (de)
JP (1) JPH09512909A (de)
KR (1) KR970702928A (de)
CN (1) CN1147270A (de)
AT (1) ATE244298T1 (de)
AU (1) AU690686B2 (de)
CA (1) CA2189470A1 (de)
DE (1) DE69531206D1 (de)
IL (1) IL113346A (de)
NZ (1) NZ285264A (de)
RU (1) RU2156619C2 (de)
TW (1) TW350913B (de)
WO (1) WO1995029985A1 (de)
ZA (1) ZA953432B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105784987A (zh) * 2016-02-29 2016-07-20 丹娜（天津）生物科技有限公司 一种新型隐球菌荚膜多糖gxm的制备方法
CN111234044B (zh) * 2020-01-19 2021-04-27 广西中医药大学 一种低分子量金耳葡糖醛酸-木甘聚糖及其制备方法和应用

Also Published As

Publication number Publication date
EP0758375A1 (de) 1997-02-19
WO1995029985A1 (en) 1995-11-09
CN1147270A (zh) 1997-04-09
US5677137A (en) 1997-10-14
EP0758375B1 (de) 2003-07-02
NZ285264A (en) 1997-11-24
AU690686B2 (en) 1998-04-30
KR970702928A (ko) 1997-06-10
AU2431095A (en) 1995-11-29
CA2189470A1 (en) 1995-11-09
IL113346A0 (en) 1995-07-31
IL113346A (en) 2000-01-31
ZA953432B (en) 1996-10-28
TW350913B (en) 1999-01-21
EP0758375A4 (de) 1997-11-26
DE69531206D1 (de) 2003-08-07
JPH09512909A (ja) 1997-12-22
RU2156619C2 (ru) 2000-09-27

Similar Documents

Publication Publication Date Title
DE60228557D1 (de) Candida-nachweis
ATE241139T1 (de) Vorrichtung zur durchführung eines oder mehrerer kompetitiver immunoassays
WO2003043487A3 (en) Method of using a non-antibody protein to detect and measure an analyte
DK0820522T3 (da) Assays og indretninger til detektering af ekstrahepatisk galdeatresi
EP1438583A4 (de) Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper-komplexe mit elisa-tests
EP1306742A3 (de) Eine grafische Schnittstelle
DE60021369D1 (de) Verfahren zur abschätzung eines magengeschwür-risikos
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
DK0648335T3 (da) Diagnostisk fremgangsmåde til bestemmelse af fødselstilbøjeligheden og reagenskit til anvendelse dertil
NO964015L (no) Fremgangsmåte for påvisning av kalpain-aktivering og identifisering av kalpain-inhibitorer
DE69105978D1 (de) Verfahren zur verminderung von störungen in einer fluoreszenzbestimmung.
ATE376672T1 (de) Verfahren zur diagnose von multipler sklerose
Yamasaki et al. Nucleolar staining cannot be used as a screening test for the scleroderma marker anti–RNA polymerase I/III antibodies
EP1476757A4 (de) Verfahren und kit zur krebsvorhersage
FI973561A7 (fi) Menetelmä ja yhdisteitä analysoitavien aineiden määrittämiseksi remane nssimittausten avulla ja mainittujen yhdisteiden käyttö
ATE244298T1 (de) Methode zur identifizierung von immungeschwächter patienten mit einem hohen risiko für cryptococcosis durch dem igg antikörperstand gegen glucoronoxylomannan zu titrieren
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
Henrich et al. Rhythmic disturbance in ataxic dysarthria: A comparison of different measures and speech tasks
DK0672756T3 (da) Monoklonalt antistof, som genkender FK506-bindende protein, fremgangsmåde til måling af niveauet af FK506-bindende protein og kit dertil
ATE421093T1 (de) Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten
ATE246809T1 (de) Verfahren zur bestimmung der alkoholkonsumrate
ATE426171T1 (de) VERFAHREN UND REAGENZ ZUR PRUFUNG VON MEHRORGANSTÍRUNG IN ßSYSTEMIC INFLAMMATORY RESPONSE SYNDROMEß (SIRS) DURCH MESSUNG VON CYTOCHROM C
ATE339683T1 (de) Verfahren zur detektion und konzentrationsbestimmung von schwefelfreien odoriermitteln in erd- oder brenngas
DE59910326D1 (de) Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties